Salute e Benessere
Dry Eye Disease Market to Observe Stupendous Growth by 2034 | DelveInsight
Discover which therapies are expected to grab the major dry eye disease market share @
Dry eye disease (DED) is a common chronic condition characterized by inadequate tear production or excessive tear evaporation, leading to inflammation and damage to the eye's surface. Causes of DED are multifactorial and include aging, hormonal changes, prolonged screen use, environmental factors (dry climates, wind), certain medications, autoimmune conditions, and contact lens wear. Symptoms often include persistent dryness, redness, irritation, a gritty or sandy sensation, sensitivity to light, blurry vision, and in some cases, paradoxical excessive tearing.
Diagnosing DED typically involves a thorough eye examination by an ophthalmologist or optometrist. Common diagnostic tests include the Schirmer test, tear breakup time, and ocular surface staining with dyes such as fluorescein or lissamine green to detect surface damage. Early diagnosis and management are essential to prevent complications like corneal damage and vision impairment.
The dry eye disease epidemiology section provides insights into the historical and current dry eye disease patient pool and forecasted trends for the 7MM. It helps recognize the causes of current and forecasted patient trends by exploring numerous studies and views of key opinion leaders.
The dry eye disease market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:
Pharmacological treatments play a pivotal role in the comprehensive management of dry eye disease. Common solutions like artificial tears provide quick relief by enhancing the tear film, while prescription medications such as cyclosporine (e.g., ) and lifitegrast (e.g., ) help alleviate symptoms through their anti-inflammatory effects. Recently approved therapies, including (cyclosporine ophthalmic solution)/CyclASol and (NOV03), offer new and promising options.
Beyond pharmacological approaches, other strategies for managing DED include in-office treatments like intense pulsed light therapy and meibomian gland expression, as well as eyelid care techniques such as warm compresses and lid scrubs. For more severe cases, lifestyle changes, punctal plugs, or scleral contact lenses may be considered to provide additional symptom relief.
The eye drop market is largely focused on alleviating dry eye symptoms using moisturizing agents such as hyaluronic acid. However, there is a notable gap in effective treatments for viral keratoconjunctivitis, a condition often mismanaged with antibiotics. Marinomed Biotech AG's MAM-1001-3 eye drops aim to address this need by leveraging Carragelose, a red seaweed-derived polymer with exceptional moisturizing and broad-spectrum antiviral properties.
Classified as a medical device and in the pre-launch phase with MDD certification, MAM-1001-3 provides dual benefits: soothing dry, irritated eyes and potentially offering a targeted solution for viral keratoconjunctivitis, thereby advancing patient care in ocular health. In summary, implementing a personalized combination of these management strategies can effectively reduce symptoms and enhance the quality of life for individuals with DED.
To know more about dry eye disease treatment guidelines, visit @
Discover more about dry eye disease drugs in development @
The dry eye disease market dynamics are expected to change in the coming years. Dry eye is a highly prevalent condition, especially among the , creating a substantial need for effective diagnosis, treatment, and management solutions. Current treatment options, such as , enable tailored approaches to address the condition. Increased public education campaigns can and encourage individuals to seek help, while , research institutions, and healthcare providers can drive the development of novel therapies and diagnostic tools for dry eye disease.
Furthermore, potential therapies are being investigated for the treatment of dry eye disease, and it is safe to predict that the treatment space will significantly impact the dry eye disease market during the forecast period. Moreover, the with improved efficacy and a further are expected to drive the growth of the dry eye disease market in the 7MM.
However, several factors may impede the growth of the dry eye disease market. Some dry eye treatments, particularly prescription medications, can cause
, while the , including medications and frequent healthcare visits, can be burdensome for patients; additionally,
and marketing expenditures for companies, and failure to properly diagnose or treat dry eye may lead to disease progression and complications, significantly impacting patient health and well-being.
Moreover, dry eye disease treatment poses a and disrupts patients' overall well-being and QOL. Furthermore, dry eye disease market growth may be offset by , , , and a . In addition, the about the disease may also impact dry eye disease market growth.
Download the report to understand which factors are driving dry eye disease market trends @
report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the dry eye disease epidemiology trends.
report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key dry eye disease companies, including among others.
report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key glaucoma companies, including among others.
report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key glaucoma companies, including among others.
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve
Shruti Thakur
info@delveinsight.com
+14699457679
www.delveinsight.com
Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/dry-eye-disease-market-to-observe-stupendous-growth-by-2034--delveinsight-302361478.html